Succinic Acid

Succinic Acid

SCHEMBL351829

O.O.O.O.O.O.O=C([O-])CCC(=O)[O-].[Na+].[Na+]

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 3/20 0.59
HDAC1 Q13547 3/20 0.59
HDAC2 Q92769 3/20 0.59
HDAC8 Q9BY41 3/20 0.59
FFAR3 O14843 2/20 0.59
CA4 P22748 3/20 0.53
CA1 P00915 4/20 0.53
CASP1 P29466 1/20 0.50
FAHD1 Q6P587 1/20 0.43
CA2 P00918 1/20 0.40
BBOX1 O75936 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL7569477 1.00 HDAC3 (0.59) HDAC3HDAC1HDAC2HDAC8FFAR3
Succinic Acid SCHEMBL3413315 1.00 HDAC3 (0.59) HDAC3HDAC1HDAC2HDAC8FFAR3
Succinic Acid SCHEMBL7759484 1.00 HDAC3 (0.59) HDAC3HDAC1HDAC2HDAC8FFAR3
Succinic Acid SCHEMBL9639572 1.00 HDAC3 (0.59) HDAC3HDAC1HDAC2HDAC8FFAR3
Succinic Acid SCHEMBL3012461 0.96 HDAC3 (0.62) HDAC3HDAC1HDAC2HDAC8FFAR3
Succinic Acid SCHEMBL24440 0.96 HDAC3 (0.62) HDAC3HDAC1HDAC2HDAC8FFAR3
Succinic Acid SCHEMBL11211761 0.92 HDAC3 (0.59) HDAC3HDAC1HDAC2HDAC8FFAR3
Succinic Acid SCHEMBL2353390 0.92 FFAR3 (0.53) HDAC3HDAC1HDAC2HDAC8FFAR3
Succinic Acid SCHEMBL8441137 0.92 HDAC3 (0.59) HDAC3HDAC1HDAC2HDAC8FFAR3
Succinic Acid SCHEMBL504448 0.92 FFAR3 (0.53) HDAC3HDAC1HDAC2HDAC8FFAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1010 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665763-A1 STABLE PROTEIN COMPOSITIONS OF ANTI-PD1 ANTIBODY Sun Pharmaceutical Industries Limited (IN) 2025-12-24 EP claimed
CN-120060003-A Pseudomonas putida and microbial inoculum with paraxylene and nitrogen removal function under anaerobic condition, and method and application thereof 安徽师范大学 2025-05-30 CN claimed
CN-119842533-A Denitrifying strain with toluene and nitrogen removal function under anaerobic condition and application thereof 安徽师范大学 2025-04-18 CN claimed
US-20250009775-A1 GENOTYPE-AGNOSTIC RESCUE OF CYSTIC FIBROSIS WITH SMALL MOLECULE BICARBONATE CHANNELS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2025-01-09 US claimed
US-20250000886-A1 GENOTYPE-AGNOSTIC RESCUE OF CYSTIC FIBROSIS WITH SMALL MOLECULE BICARBONATE CHANNELS UNIVERSITY OF IOWA RESEARCH FOUNDATION 2025-01-02 US claimed
EP-3694526-B1 GENOTYPE-AGNOSTIC RESCUE OF CYSTIC FIBROSIS WITH SMALL MOLECULE BICARBONATE CHANNELS UNIV ILLINOIS (US) 2024-12-04 EP claimed
US-12090164-B2 Genotype-agnostic rescue of cystic fibrosis with small molecule bicarbonate channels THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2024-09-17 US claimed
WO-2024171082-A1 STABLE PROTEIN COMPOSITIONS OF ANTI-PD1 ANTIBODY SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2024-08-22 WO claimed
CN-118239511-A Rod-shaped nano zinc oxide and preparation method thereof, polylactic acid composite material and preparation method thereof 甘肃旭碳新材料有限公司 2024-06-25 CN claimed
CN-117511784-A Heterotrophic nitrification aerobic denitrification strain, immobilized pellet, preparation method and application 湖南农业大学 2024-02-06 CN claimed
WO-2007088038-A1 HYDROGEL EURO-CELTIQUE S.A. (LU) 2007-08-09 WO claimed
EP-1815877-A1 Hydrogel EURO-CELTIQUE S.A. (LU) 2007-08-08 EP claimed
EP-1787640-A1 TIME-LIMITED RELEASE TYPE GRANULAR PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION AND INTRAORAL RAPID DISINTEGRATION TABLET CONTAINING THE COMPOSITION Astellas Pharma Inc. (JP) 2007-05-23 EP claimed
US-7175853-B1 Therapeutic system which can be moisture-activated LTS LOHMANN THERAPIE-SYSTEME AG (DE) 2007-02-13 US claimed
EP-1631305-A2 SINCALIDE FORMULATIONS Bracco International B.V. (NL) 2006-03-08 EP claimed
US-20050287211-A1 Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition ASTELLAS PHARMA INC. (JP) 2005-12-29 US claimed
WO-2005027954-A2 SINCALIDE FORMULATIONS BRACCO INTERNATIONAL B.V. (US) 2005-03-31 WO claimed
US-6803046-B2 CONTAINING STABILIZER, SOLUBILIZER, CHELATOR, BULKING AGENT, TONICITY ADJUSTER AND BUFFER; FEWER DEGRADANTS; CONSISTENT POTENCY BRACCO INTERNATIONAL B.V. (NL) 2004-10-12 US claimed
US-20040033243-A1 CONTAINING STABILIZER, SOLUBILIZER, CHELATOR, BULKING AGENT, TONICITY ADJUSTER AND BUFFER; FEWER DEGRADANTS; CONSISTENT POTENCY BRACCO DIAGNOSTICS INC. 2004-02-19 US claimed
US-6096348-A MIXTURE OF HYDROGEN PEROXIDE, DICARBOXYLIC ACID BUFFER AND WATER; MEDICAL EQUIPMENT HEALTHPOINT, LTD. (US) 2000-08-01 US claimed